首页 > Encapsula > Encapsula/ImmunoFluor™-NHS (PEGylated) (Post-insertion)/2-ml/IMF-3104

提醒：代购产品，无质量问题不接受退换货，下单前请仔细核对信息。下单后请及时联系客服核对商品价格，订单生效后再付款。

Encapsula/ImmunoFluor™-NHS (PEGylated) (Post-insertion)/2-ml/IMF-3104

价格：

登录查看

自营商城

解放采购

正品保障

及时交付

厂家直采

一站服务

货号：

IMF-3104

品牌：

Encapsula

会员服务：

尊享会员价

贵宾专线

运费优惠

闪电退款

福利优惠

上门换新

友情提示

以上价格仅为参考，请联系客服询价。

免费咨询热线

4000-520-616

产品说明

iposome formulations can be broadly divided into cationic, anionic and neutral subtypes. Cellsome® liposomes made from neutral PEGylated lipids provide certain benefits. One of the most well-known Neutral PEGylated Lipids used if for the drug Doxil®. Liposomal doxorubicin (Doxil®) is a liposome formulation encapsulating the chemotherapeutic drug, doxorubicin, thereby decreasing its toxicity.To improve liposome stability and enhance their circulation times in the blood, a sterically-stabilized, hydrophilic polymer, polyethylene glycol (PEG), has been shown to be the optimal choice for obtaining sterically-stabilized liposomes. Using a Neutral Liposome with PEG will protect the liposomes from circulating proteins, improving their plasma clearance and enhancing their therapeutic effects. Doxil® also contains polyethylene glycol (PEG)-lipid resulting in pegylation of the liposome surface, which enables it to have a prolonged circulation and a reduced volume of distribution, thereby improving tumor uptake through the enhanced permeability and retention effect (EPR) and extending effective tumor therapy.The three products provided that are made from Neutral PEGylated Lipids provided here consist of either HSPC:Chol:DSPE-PEG(2000) (65:30:5 molar ratio), DSPC:Chol:DSPE-PEG(2000) (65:30:5 molar ratio), or DOPC:Chol:DOPE-PEG(2000) (65:30:5 molar ratio).